Anastasios Gianakakos - 21 Jun 2023 Form 4 Insider Report for LianBio (LIANY)

Role
Director
Signature
By: /s/ Angela Chen, Attorney-in-Fact
Issuer symbol
LIANY
Transactions as of
21 Jun 2023
Net transactions value
$0
Form type
4
Filing time
23 Jun 2023, 16:22:08 UTC
Previous filing
27 Jun 2022
Next filing
20 Feb 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LIAN Stock Option (Right to Buy) Award $0 +36,300 $0.000000 36,300 21 Jun 2023 Ordinary Shares 36,300 $2.40 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares underlying the option shall vest and become exercisable in full on June 21, 2024, the first anniversary of the grant date, subject to the Reporting Person providing continuous service to the Issuer through such date.